Cargando…

Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence?

C1q nephropathy is a glomerulopathy that is characterized by large amount of C1q deposits in the glomerular mesangium. It is a diagnosis of exclusion after ruling out systemic lupus erythematosus and membranoproliferative glomerulonephritis by systemic and serological examination. The pathogenesis o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Rui, Wu, Dengyan, He, Zhiqin, Chang, Qian, Yang, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902059/ https://www.ncbi.nlm.nih.gov/pubmed/33634050 http://dx.doi.org/10.3389/fped.2020.568773

Ejemplares similares

Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
por: Wang, Xiao-Pei, et al.
Publicado: (2016)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr108Met Variant of Aquaporin 2
por: Ma, Lina, et al.
Publicado: (2020)

Complete Remission in a Child With Multisystem Inflammatory Syndrome and Stevens-Johnson Syndrome Treated With Infliximab
por: Lootah, Shamma, et al.
Publicado: (2023)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
por: Topaloğlu, Rezan, et al.
Publicado: (2019)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Remission and long-term remission of pediatric-onset systemic lupus erythematosus
por: Chen, Yi-Chieh, et al.
Publicado: (2023)

Two cases of idiopathic membranous nephropathy treated with rituximab
por: Young Yoon, Jae, et al.
Publicado: (2013)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients – A Mere Coincidence?
por: Karastaneva, Anna, et al.
Publicado: (2015)

Membranous nephropathy with systemic light-chain amyloidosis of remission after rituximab therapy: A case report
por: Zhang, Jiao, et al.
Publicado: (2023)

Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021)

Case Report and Review of the Literature: Congenital Diaphragmatic Hernia and Craniosynostosis, a Coincidence or Common Cause?
por: Gaillard, Linda, et al.
Publicado: (2021)

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
por: Bagchi, Soumita, et al.
Publicado: (2018)

Clinical Features and Remission Rate of Pediatric Graves’ Hyperthyroidism Treated With Antithyroid Drug
por: You, Kyusang, et al.
Publicado: (2021)

A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab: A long-term follow-up
por: Zhou, Xu-Jie, et al.
Publicado: (2018)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

COVİD-19 infection in a membranous nephropathy patient treated with rituximab
por: Elcioglu, Omer Celal, et al.
Publicado: (2020)

A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
por: Wennmann, Merlin, et al.
Publicado: (2021)

The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy
por: Duan, Suyan, et al.
Publicado: (2023)

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
por: Gao, Xia, et al.
Publicado: (2021)

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
por: Cortazar, Frank B., et al.
Publicado: (2017)

Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
por: Chen, Xian, et al.
Publicado: (2023)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells
por: Webendörfer, Maximilian, et al.
Publicado: (2021)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

Corticosteroids in Pediatric Heart Surgery: Myth or Reality
por: Fudulu, Daniel P., et al.
Publicado: (2018)

Persistent Abnormalities of Fatty Acids Profile in Children With Idiopathic Nephrotic Syndrome in Stable Remission
por: Turolo, Stefano, et al.
Publicado: (2021)

Effects of Inhaled Corticosteroids on Lung Function in Children With Post-infectious Bronchiolitis Obliterans in Remission
por: Zheng, Haoqi, et al.
Publicado: (2022)

Predictive Value of Magnetic Resonance Imaging in Patients With Juvenile Idiopathic Arthritis in Clinical Remission
por: Mazzoni, Marta, et al.
Publicado: (2022)

The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis
por: Liu, Sidi, et al.
Publicado: (2021)

Clinical features and gene variation analysis of COQ8B nephropathy: Report of seven cases
por: Liang, Rui, et al.
Publicado: (2023)

Clinical, Laboratory, and Molecular Characteristics and Remission Status in Children With Severe Congenital and Non-congenital Neutropenia
por: Gong, Ruo-Lan, et al.
Publicado: (2018)

Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
por: Xue, Cheng, et al.
Publicado: (2023)

The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
por: Zhao, Jingying, et al.
Publicado: (2021)

Corrigendum: Clinical features and gene variation analysis of COQ8B nephropathy: Report of seven cases
por: Liang, Rui, et al.
Publicado: (2023)

Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia
por: Kleef, Ralf, et al.
Publicado: (2021)

Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia
por: Al-taweel, Heba Mohamed, et al.
Publicado: (2023)

Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
por: Wang, Yao-Wei, et al.
Publicado: (2023)

Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy
por: Sato, Hirotaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_15j8t3amup0t7vpg1mc3dvp22a